(Q44216400)

English

Effect of cessation of highly active antiretroviral therapy during a discordant response: implications for scheduled therapeutic interruptions.

scientific article published on 21 June 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438900%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Effect of cessation of highly active antiretroviral therapy during a discordant response: implications for scheduled therapeutic interruptions (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438900%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Jonathan B Angel

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438900%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Hawley-Foss N

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438900%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Mbisa G

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438900%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Lum JJ

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438900%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Pilon AA

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438900%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Garber G

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438900%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Badley AD

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438900%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

language of work or name

0 references

publication date

21 June 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438900%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Clinical Infectious Diseases

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438900%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

33

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438900%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438900%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

344-348

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11438900%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Effect of the human immunodeficiency virus epidemic on mortality from opportunistic infections in the United States in 1993.

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

Decline in deaths from AIDS due to new antiretrovirals

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

Outcome and predictors of failure of highly active antiretroviral therapy: one-year follow-up of a cohort of human immunodeficiency virus type 1-infected persons

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

In vivo emergence of HIV-1 variants resistant to multiple protease inhibitors

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

Sustained CD4+ T cell response after virologic failure of protease inhibitor-based regimens in patients with human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

High levels of drug-resistant human immunodeficiency virus variants in patients exhibiting increasing CD4+ T cell counts despite virologic failure of protease inhibitor-containing antiretroviral combination therapy

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

HIV RNA and CD4 cell count response to protease inhibitor therapy in an urban AIDS clinic: response to both initial and salvage therapy

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

Decreased HIV-associated T cell apoptosis by HIV protease inhibitors.

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

A controlled trial of early versus late treatment with zidovudine in symptomatic human immunodeficiency virus infection. Results of the Veterans Affairs Cooperative Study

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

Impaired infectivity of HIV-1 after a single point mutation in the POL gene to escape the effect of a protease inhibitor in vitro

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

Dynamics of viral load rebound and immunological changes after stopping effective antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

Strong human immunodeficiency virus (HIV)-specific CD4+ T cell responses in a cohort of chronically infected patients are associated with interruptions in anti-HIV chemotherapy

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy.

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

Control of HIV despite the Discontinuation of Antiretroviral Therapy

1 reference

https://api.crossref.org/works/10.1086%2F321902

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44216400&oldid=2108629001"